I
InspireMD Inc (NSPR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
$0.60
-0.04 (-6.85%)
Market Cap: $30.13M
Last updated: Nov 17, 2026 at 11:05 AM ET
InspireMD Inc (NSPR) Valuation Multiples
InspireMD (NSPR) trades at 4.9x sales and 2.4x book value. Its P/S of 4.9x is below its 5-year median of 7.7x. Its forward P/E is 11.7x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 11.7x |
| Price to sales | 4.9x |
| Price to book | 2.4x |
| PEG | N/A |
| FCF yield | -82.7% |
Historical Medians
Against its 10-year medians, its P/B is 140.0% above 1.0x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 4.9x | 7.7x | N/A |
| P/B | 2.4x | 1.8x | 1.0x |
Valuation History
Over the 7 of the 10 year ends shown that have a P/S, its P/S ranged from 0.5x in 2019 to 15.5x in 2024.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $1.78 | 12.5x | 2.4x |
| 2024 | $2.63 | 15.5x | 3.6x |
| 2023 | $2.81 | 8.0x | 1.7x |
| 2022 | $0.86 | 1.3x | 0.4x |
| 2021 | $3.02 | 4.9x | 0.7x |
| 2020 | $5.11 | 1.2x | 1.1x |
| 2019 | $16.19 | 0.5x | 0.9x |
| 2018 | $119.12 | N/A | 0.8x |
| 2017 | $3,407.39 | N/A | 0.3x |
| 2016 | $65,526.68 | N/A | N/A |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NSPR
What is NSPR's forward P/E ratio?
InspireMD has a forward P/E ratio of 11.7x.
Is NSPR stock overvalued?
GNG's valuation label for NSPR is Fairly valued.
What is NSPR's price to sales ratio?
InspireMD has a price to sales ratio of 4.9x.
NSPR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors